TherapeuticsMD (TXMD) Launches Third Prescription Prenatal Vitamin
VitaMedMD™ RediChew™ Rxchewable prenatal vitamin contains company’s patented folate developed to further reduce impact of folic acid-related deficiencies. TherapeuticsMD™ Inc., parent company of vitaMedMD® LLC, a specialty pharmaceutical company focused on therapies exclusively for women, today announced the recent launch of its third prescription prenatal vitamin, vitaMedMD™RediChew™ Rx. The launch trails the introduction of vitaMedMD™ One Rx earlier this month and vitaMedMD™ Plus Rx last month, products similar to RediChew Rxin that they all contain the same combination of folic acid and the company’s patented fourth-generation folate, Quatrefolic®. Quatrefolic gives all three of the prenatal vitamins the potential to further…